Omeprazol-Mepha 20 mg, magensaftresistente Kapseln

7680628750346 CH-62875 Magensaftresistente Kapseln

Associated product:

OMEPRAZOL Mepha caps 20 mg bte 14 pce
Omeprazol-Mepha 20 mg, magensaftresistente Kapseln
Omeprazol-Mepha 20 mg, magensaftresistente Kapseln
Omeprazol-Mepha 20 mg, magensaftresistente Kapseln
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Kapsel(n)
Galenic form
Magensaftresistente Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/07/2024
Patient information leaflet
Français
16/07/2024
Patient information leaflet
Italien
16/07/2024
Summary of Product Characteristics
Allemand
16/07/2024
Summary of Product Characteristics
Français
16/07/2024
Summary of Product Characteristics
Italien
16/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
80.02 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
1.51 MG Substance HBESI

Reimbursement information

Public price
CHF 15.40
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2015

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62875
Drug name
Omeprazol-Mepha, magensaftresistente Kapseln
Galenic form
KAHAM
ATC Code
A02BC01
Authorization status
Z
Dispensing category
B
First authorization
20/11/2013
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Ulcustherapie, Zollinger-Ellison-Syndrom

Package details

Description (FR)
OMEPRAZOL Mepha caps 20 mg bte 14 pce
Description (DE)
OMEPRAZOL Mepha Kaps 20 mg Ds 14 Stk
Market launch
20/11/2013
Narcotic (BTM)
No

Original drug

Antramups, Tabletten
GTIN: 7680543800386
CHF 16.20
View original

Other package sizes (10)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
OMEPRAZOL Mepha caps 10 mg bte 14 pce
14 KAP
GTIN: 7680628750292
View
OMEPRAZOL Mepha caps 10 mg bte 28 pce
28 KAP
GTIN: 7680628750308
View
OMEPRAZOL Mepha caps 10 mg bte 56 pce
56 KAP
GTIN: 7680628750315
View
OMEPRAZOL Mepha caps 10 mg bte 98 pce
98 KAP
GTIN: 7680628750322
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1